Navigation Links
Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
Date:1/14/2014

New York, NY (PRWEB) January 14, 2014

As dozens of Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) alleging use of the statin caused patients to develop Type 2 diabetes continue to move forward in courts around the country, Bernstein Liebhard LLP notes that Pfizer Inc. has also been named a defendant in a new whistleblower lawsuit involving the cholesterol-lowering medication. The complaint, which was filed on behalf of the federal government by Health Support Awareness Inc., accuses Pfizer of deceptively marketing Lipitor in a way that resulted in fraud against Medicare, Medicaid and others. The Lipitor whistleblower lawsuit, which was unsealed on January 10, 2014 in the U.S. District Court, District of Massachusetts, was filed under the federal False Claims Act, a law which allows private citizens or entities to bring suit against defendants that have allegedly defrauded the U.S. government. (United States of American vs. Pfizer Inc., 1:13-cv-11917)

“Numerous Lipitor lawsuits have already been filed against Pfizer by individuals who were allegedly harmed by this drug. We will be monitoring the progress of this whistleblower lawsuit very closely, as such cases often bring evidence to light that might be relevant in other claims,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit reviews to anyone who may have developed new-onset Type 2 diabetes due to the use of this statin medication.

Lipitor Lawsuits
According to court documents, Pfizer has been named in at least 100 product liability lawsuits that allege a connection between Lipitor and diabetes. On January 30, 2014, the U.S. Judicial Panel on Multidistrict Litigation will hear oral arguments regarding the possible consolidation of federally-filed Lipitor diabetes claims in a single jurisdiction for pretrial proceedings. All of these lawsuits accuse Pfizer of failing to provide adequate warnings regarding the risks associated with the statin medication. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))

In February 2012, the U.S. Food & Drug Administration (FDA) ordered Pfizer to add new warnings to the Lipitor label regarding its possible association with an increased risk of new-onset Type 2 diabetes. The FDA acted after research published in JAMA: Internal Medicine reported that post-menopausal women treated with statins were at increased risk of developing diabetes.*

In May 2013, the British Medical Journal published a study which found Lipitor patients faced a 22 percent increased risk of developing Type 2 diabetes.**

Individuals who allegedly developed diabetes due to their use of Lipitor may be entitled to compensation from Pfizer. To find out more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
**bmj.com/content/346/bmj.f2610, BMJ, May 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.thelipitorlawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11488510.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of New Study with Possible Explanation for Link between Statins and Diabetes
2. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New Statin Guidelines That Could Result in Millions of New Lipitor Prescriptions
3. New Lipitor Diabetes Lawsuit Alleges Statin Drug Caused Woman to Develop Type 2 Diabetes, Learns Wright & Schulte LLC
4. Lipitor Lawsuits Continue to Mount, as Bernstein Liebhard LLP Notes Filing of New Claim Alleging an Association Between Lipitor and Diabetes
5. Dozens of Lipitor Lawsuits Involving Diabetes Allegations Moved to Federal Court, Bernstein Liebhard LLP Reports
6. Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
7. Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
8. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
9. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
10. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
11. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: